Hippocampal atrophy, as evidenced using magnetic resonance imaging (MRI), is one of the
most validated, easily accessible and widely used biomarkers of Alzheimer's disease (AD) …

Background: Histopathological studies and animal models suggest that hippocampal
subfields may be differently affected by aging, Alzheimer's disease (AD), and other diseases …

Background The hippocampus and hippocampal subfields have been found to be diversely
affected in Alzheimer's Disease (AD) and early stages of Alzheimer's disease by …

Background Hippocampal atrophy is a well-known feature of Alzheimer's disease (AD), but
sensitivity and specificity of hippocampal volumetry are limited. Neuropathological studies …

Recent advances in neuroimaging have highlighted the interest to differentiate hippocampal
subfields for cognitive neurosciences and more notably in assessing the effects of normal …

Growing interest has developed in hippocampal subfield volumetry over the past few years
and an increasing number of studies use the automatic segmentation algorithm …

The measurement of hippocampal volumes using MRI is a useful in-vivo biomarker for
detection and monitoring of early Alzheimer's disease (AD), including during the amnestic …

Previous studies have shown that hippocampal subfields may be differentially affected by
Alzheimer's disease (AD). This study used an automated analysis technique and two large …

We present and evaluate a new method for automatically labeling the subfields of the
hippocampal formation in focal 0.4× 0.5× 2.0 mm3 resolution T2-weighted magnetic …

Hippocampal subfields exhibit differential vulnerabilities to Alzheimer's disease-associated
pathology including abnormal accumulation of amyloid-β deposition and neurofibrillary …